Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas Disclosure of Research Ananlyst Annual Compliance Audit Report
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
RPG Life Sciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 532983 border-img ISIN Demat INE105J01010 border-img Book Value 334.94 border-img NSE Symbol RPGLIFE border-img Div & Yield % 1.19 border-img Market Cap (₹ Cr.) 3345.02 border-img P/E 31.84 border-img EPS 63.52 border-img Face Value 8
ParticularsMar 2025
(₹)		Mar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)
INCOME :       
Sales Turnover 653.43582.05512.81440.16389.14375.57
Excise Duty 0.000.000.000.000.000.00
Net Sales 653.43582.05512.81440.16389.14375.57
Other Income 111.617.214.802.990.910.73
Stock Adjustments -8.61-2.707.3025.215.015.98
Total Income 756.43586.56524.91468.36395.06382.28
EXPENDITURE :       
Raw Materials 205.40181.83178.17167.03136.11133.74
Power & Fuel Cost 17.6614.3613.6512.6911.2711.54
Employee Cost 126.14132.15117.0699.9794.6690.97
Other Manufacturing Expenses 28.2326.0721.6022.6118.4813.72
Selling & Administrative Expenses 95.4980.4773.6367.0758.4056.84
Miscellaneous Expenses 27.6115.3312.478.754.3019.90
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 500.53450.21416.58378.12323.22326.71
Operating Profit 255.90136.35108.3390.2471.8455.57
Interest 1.591.441.151.411.792.76
Gross Profit 254.31134.91107.1888.8370.0552.81
Depreciation 21.4317.0715.5015.6616.4716.36
Profit Before Tax 232.88117.8491.6873.1753.5836.45
Tax 49.6932.5424.3522.7617.1510.10
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax -0.05-2.36-0.31-1.07-3.57-2.66
Reported Net Profit 183.2487.6667.6451.4840.0029.01
Extraordinary Items 67.660.77-0.570.61-0.01-3.93
Adjusted Net Profit 115.5886.8968.2150.8740.0132.94
Adjustment below Net Profit -1.10-0.560.07-0.25-0.12-0.17
P & L Balance brought forward 318.48251.23199.40160.08120.20104.13
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 26.4619.8515.8811.910.0012.77
P & L Balance carried down 474.16318.48251.23199.40160.08120.20
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 300.00200.00150.00120.0090.0050.00
Dividend Per Share(Rs) 24.0016.0012.009.607.204.00
Earnings Per Share-Unit Curr 110.8053.0140.9031.1324.1917.54
Earnings Per Share(Adj)-Unit Curr 110.8053.0140.9031.1324.1917.54
Book Value-Unit Curr 320.80226.67186.00154.66130.88106.77
Book Value(Adj)-Unit Curr 320.80226.67186.00154.66130.88106.77
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109 | Mutual Fund Distributor with AMFI (AMFI Registration Number - 20149) |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

We are integrated with TradingView, a leading charting platform providing advanced financial visualization tools, technical indicators, and market analysis capabilities for traders and investors worldwide.

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
imsl-img
close
refresh